ReviewCardiovascular and interventional radiology2025
Hydrophilic Polymer Embolism: An Underappreciated Complication of Endovascular Procedures that Physicians Should be Aware Of.
Review in Cardiovascular and interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Granulomatous Vasculitis in Cutaneous Hydrophilic Polymer Embolism.The Journal of dermatology · 2026Article
- Remove, Exclude, Ablate: Adding to the Algorithm of Entrapped Equipment Management in Percutaneous Coronary Intervention.JACC. Case reports · 2026Article
- Hydrophilic Polymer Embolism and Silent Brain Injury: An Underexplored Connection.Cardiovascular and interventional radiology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hydrophilic polymer embolization (HPE) represents a complication of endovascular interventions, occurring when the hydrophilic coating detaches, eventually causing distal ischemia and/or inflammation. We conducted a scoping review using PubMed, providing a summary of the main clinical implications potentially related to HPE. The analysis primarily found case reports/series (n = 48/56), suggesting that this event is perceived as sporadic. However, the potentially subtle presentation of HPE and a limited understanding of this condition among medical professionals are likely to contribute to its underrepresentation in medical literature. To better understand HPE risks, a detailed device analysis considering material and coating variations is crucial. Collaboration among manufacturers, clinicians, and regulators is needed to improve safety, diagnostics, and patient outcomes, bridging knowledge gaps and addressing this complex issue effectively.
Indexed as
Identifiers
40540040What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.